Wadsworth Center Based University at Albany Doctoral Student Receives Recognition for Outstanding Poster Presentation

University at Albany PhD student Ryan Gainor was recognized for his poster presentation at the University at Albany Showcase 2026. Ryan is a second-year doctoral student in the Department of Environmental Health Sciences within the Center for Integrated Health Sciences and conducts research in the Division of Environmental Health Sciences at the Wadsworth Center. 

Two New York Birth Hospitals Selected as Recruitment Sites for National Newborn Genome Sequencing Study

Two New York birth hospitals have been selected to partner with the Wadsworth Center as recruitment sites for BEACONSNBS (Building Evidence and Collaboration for GenOmics in Nationwide Newborn Screening), a national research study evaluating the use of genome sequencing in newborn screening.

Wadsworth Center Scientist Co-Leads National Newborn Screening Subcommittee Meeting

Dr. Denise Kay, Director of the Newborn Screening Program at the Wadsworth Center, attended a meeting of the Association of Public Health Laboratories (APHL) Newborn Screening Molecular Subcommittee at the Centers for Disease Control (CDC) and Prevention in Atlanta. As Co-Chair of the subcommittee, Dr. Kay co-led the meeting.

Mentor Training at the University at Albany and the Wadsworth Center

Janice Pata, Director of the Division of Scientific Cores at the Wadsworth Center, advanced the longstanding educational partnership between the New York State Department of Health and the University at Albany during the 2025–2026 academic year by facilitating the nationally recognized Entering Mentoring program for the first time at the university.

Wadsworth Center Expands Technical Competence in Programming Skills

Rapid advances in laboratory instrumentation, automation, and computational technologies have created unprecedented opportunities to strengthen the prevention, detection, and response to public health threats. The Wadsworth Center’s Community, Advancement, Recruitment, and Engagement (CARE) program has focused on promoting the adoption of automated workflows by ensuring that staff have access to high-quality training resources and in-house expertise. 

Wadsworth Center Publication: How Medically Important Antimicrobials Bind to the Ribosome in the Lyme Disease Pathogen

In a study recently published in Biochemistry, Dr. Nilesh Banavali, and colleagues in the Wadsworth Center's Division of Genetics, describe how medically important antibacterials bind to ribosomes of Borrelia burgdorferi, the causative agent of Lyme disease. The team predicted detailed atomic structures and binding affinities for multiple antibacterials interacting with the pathogen’s ribosomal small subunit. Why this is a breakthrough:

Wadsworth Center scientist receives award to research Staphylococcus aureus envelope biogenesis and combat antimicrobial resistance

Dr. Thomas Bartlett, a new Principal Investigator in the Wadsworth Center’s Division of Genetics, has been awarded a New York Community Trust award for his grant proposal entitled “Finding New Gaps in the Cell Wall of Drug-Resistant Staphylococcus aureus.”

Nobel Laureate Dr. Venki Ramakrishnan Gives Wadsworth Seminar

“Initiation of Translation by the Ribosome”Ribosomes are cellular machines that conduct protein synthesis (or gene translation) in both bacteria and higher organisms such as humans. The mechanism of initiation of translation is among the most fundamental and highly regulated cellular processes.  Dr. Ramakrishnan's presentation focused primarily on how translation works in eukaryotic cells. Dr.

Caleb Mallery, Wadsworth Center PhD Candidate, Awarded Prestigious NIH F31 Fellowship for Infectious Disease Research

Caleb Mallery, a fourth-year PhD candidate in the Paczkowski Lab within the Division of Genetics at the Wadsworth Center and a student in the Department of Biomedical Sciences at the University at Albany, has been awarded a prestigious F31 predoctoral fellowship from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. His research focuses on Pseudomonas aeruginosa, a significant cause of hospital-acquired infections, particularly among individuals with cystic fibrosis and those with weakened immune systems.